Effect of Hepatic Impairment on the Pharmacokinetics of the Novel Glycopeptide Oritavancin

Primary Cognigen Author: Gerald Fetterly, Ph.D. Primary InterMune Author: L. Morello

Event: AAPS Annual Meeting Baltimore, MD November 7-11, 2004

Primary Cognigen Author: Gerald Fetterly, Ph.D.

Primary Intermune Author: L. Morello

Other Contributors:

Cognigen Corporation:

Joel Owen, Ph.D., Sujata Bhavnani, M.S., Ph.D., Paul Ambrose, Ph.D.

Intermune, Inc.:

J.S. Loutit, S.B. Porter